Page last updated: 2024-11-04

temozolomide and Lewy Body Disease

temozolomide has been researched along with Lewy Body Disease in 1 studies

Lewy Body Disease: A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present. (From Neurology 1997;48:376-380; Neurology 1996;47:1113-1124)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wong, ET1
Rosenberg, H1
Dawood, O1
Hertan, L1
Vega, RA1
Anderson, M1
Uhlmann, EJ1

Other Studies

1 other study available for temozolomide and Lewy Body Disease

ArticleYear
Lewy body disease as a potential negative outcome modifier of glioblastoma treatment: a case report.
    BMC neurology, 2023, Jul-04, Volume: 23, Issue:1

    Topics: Aged; Brain; Glioblastoma; Humans; Lewy Bodies; Lewy Body Disease; Male; Temozolomide

2023